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Abstract
Three integral parts that cover the ocular surface are the conjunctiva, limbus, and cornea. 
The conjunctiva is a see-through mucous membrane that lines the internal surface of the 
eyelids and the front surface of the eyeball, ending at the limbus. It is highly vascular with 
a dense lymphatic network. The limbus forms the boundary between the transparent cor-
nea and the opaque sclera. The cornea is a complex structure that provides a protective 
function and is responsible for about 75% of the optical power of the eye. Histology of 
these highly specialized biological materials as well as the ways in which individual com-
ponents are structurally and functionally related will be discussed in this chapter. Then, 
we will go over the pathological oncology processes that can affect the ocular surface.
Keywords: histology, histopathology, ocular surface, conjunctiva, limbus, cornea, 
epithelium, stroma, endothelium, squamous cell carcinoma, melanoma
1. Introduction
The ocular surface is an anatomic entity that is composed of different ocular structures: con-
junctiva, limbus, and cornea. A healthy ocular surface should have a healthy tear film over-
lying it. The maintenance of ocular surface in an optimal and healthy state contributes both 
esthetic and functional wellness of the eye.
From the anatomic point of view, the ocular surface includes the mucosal epithelium limited 
by the skin of the free edge of the eyelids. It includes the cornea and the conjunctiva. The inter-
dependence of the structures integrated into this system and their influence on the corneal 
epithelium and ultimately on the eyeball makes them of great importance to the health of the 
eye. In addition, the primordial cells of the corneal epithelium are located at the corneoscleral 
limbus.
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Tumors of the conjunctiva can arise from any of the cells that are naturally present and are 
evident histologically; thus, there is a wide variety of these tumors. They originate from the 
squamous epithelium, melanocytes, and lymphocytic cells found in the conjunctival stroma. 
The epithelial and melanocytic origins are more frequent.
This chapter will start by describing the normal histology of the ocular surface with selected 
correlated functional aspects of the biologic micro-design. Afterward, the most important 
malignant neoplastic processes affecting the conjunctiva will be reviewed along with the lat-
est updates in the medical literature.
2. Histology of ocular surface
2.1. Conjunctiva
The conjunctiva is a transparent mucous membrane that covers the ocular surface from the 
limbus to the mucocutaneous junction. It plays an essential role in maintaining a healthy and 
optically clear cornea. The part covering the sclera is known as the bulbar conjunctiva, while 
the palpebral conjunctiva lines the posterior surface of the eyelids. The forniceal conjunctiva is 
the portion that connects the bulbar with the palpebral parts. The bulbar conjunctiva is loosely 
attached to the underlying Tenon’s capsule except at the limbus where they fuse together. The 
palpebral part is tightly adherent to the tarsus, while the forniceal portion is loose and redun-
dant. A crescent-shaped fold of the conjunctiva called the plica semilunaris is found nasally. 
Medial to the plica lies the caruncle, a pinkish globular nodule that contains sebaceous glands 
and hair follicles in addition to the adnexal elements of the conjunctival stroma.
The surface layer of the conjunctiva is composed of non-keratinizing stratified squamous epi-
thelium with numerous goblet cells. Melanocytes are normally present in the basal layer of the 
epithelium. The morphology and the number of layers of the conjunctival epithelial cells change 
according to the region from which a biopsy was taken. There are approximately six to nine layers 
of stratified squamous epithelium in the bulbar conjunctiva. The epithelial cells are columnar in the 
forniceal part and cuboidal in the area attached to the tarsus where the epithelial cells are packed 
in two to five layers. The goblet cells are distributed throughout the bulbar and tarsal conjunctiva 
and are most concentrated inferonasally and in the region of the caruncle and plica semilunaris.
The conjunctival stroma (substantia propria) is a thin, richly vascularized layer enclosing 
scattered lacrimal glands (based on the anatomic location), lymphatics, plasma cells, macro-
phages, and mast cells. Additionally, it comprises numerous elastic fibers that facilitate globe 
movement in all gazes. Specialized collections of T and B lymphocytes underlying a modified 
epithelium is known as conjunctiva-associated lymphoid tissue (CALT). It functions to pro-
cess antigens and provides immunity against pathologic microbes on the ocular surface [1]. 
Conjunctival stem cells are scattered throughout the bulbar or forniceal conjunctiva.
2.2. Corneoscleral limbus
The limbus is the transitional region between the corneal margin and the anterior sclera. It 
is approximately 1–1.5 mm wide. The limbus contains the corneal stem cells located in the 
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basal cell layer. There are histological, pathological, and surgical definitions of the limbus. 
Histologically, the central margin of the limbus is limited by a line connecting the peripheral 
termination of Bowman’s layer externally and Schwalbe’s line, the peripheral termination of 
Descemet’s membrane, internally. The peripheral margin of the limbus is bounded by the 
central margin of the scleral spur. The peripheral margin from pathologist’s point of view is 
formed by a vertical line that is perpendicular to the scleral spur [1].
Surgically, the limbus is divided into two zones: a central blue-gray zone and a peripheral white 
zone. The central zone corresponds to the area connecting Bowman’s layer and Descemet’s 
membrane. The peripheral zone overlies the trabecular meshwork [2].
2.3. Cornea
The cornea is the anterior and transparent portion of the fibrous tunic of the eye globe and 
is the most powerful refractive element of the optical system of the eye. Its transparency is a 
function of different factors: avascularity, relative acellularity, relative dehydration, and the 
remarkable organization of the stromal collagen lamellae. The anterior surface of the cornea 
measures 11–12 mm horizontally and 10–11 mm vertically. The thickness of the cornea is 
0.52 mm centrally and 0.65 mm peripherally. The water content is 78% and is controlled by 
intact epithelium and endothelium. Its refractive index is 1.376 [1].
In the following sections, the histology of the different layers of the cornea will be described 
from anterior to posterior: the epithelium, Bowman’s layer, stroma, Descemet’s membrane, 
and endothelium.
2.3.1. Epithelium
The corneal epithelium is the outermost layer of the cornea and is derived from the embryonic 
surface ectoderm. It is composed of 4–5 multilayered stratified, non-keratinized squamous 
epithelium with an underlying single layer of basal cells. It is continuous with the conjunc-
tival epithelium at the limbus. Its overall thickness is approximately 50 μm with a complete 
turnover in 7–10 days. This multilayered epithelium is distributed in three strata: superficial 
flattened cells, middle wing cells, and deep basal cells [1].
The basal cell layer is considered the mother of the overlying cells, i.e., wing and the super-
ficial cells. The basal cell density is approximately 6000 cells/mm2. They originate from the 
corneal limbal stem cells. The new cells travel from the limbus in a centripetal manner at a rate 
of approximately 120 μm/week. The cells communicate with each other through gab junctions 
and actively secrete their basal lamina (50 nm thick, type IV collagen) where they adhere to it 
via hemidesmosomes. Alteration of hemidesmosomes can result in recurrent epithelial ero-
sions, as seen in patients with epithelial basement membrane dystrophy (EBMD) [1].
Wing cell layer is composed of 2–3 cell rows that overly the basal cells. These cells are given 
this name because they have extensions that make them resemble wings in cross section. They 
are attached to each other by zonulae occludentes that form a semipermeable membrane, an 
important factor preventing components of the tear film to get into the corneal stroma. The 
outermost layer is 2–3 rows of flattened cells that are shed in the tear film to be replaced by 
other cells. The ultrastructure of their apical surfaces is rough and quite irregular owing to 
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the presence of countless microplicae and microvilli. All epithelial cells are connected to each 
other by desmosomes and communicate via gap junctions. Reduction of the number of des-
mosomes is noted in patients with topical anesthetic abuse [3].
Growth factors secreted by the lacrimal glans and corneal epithelial cells play an essential 
role in the maintenance of healthy epithelial cells. Among which, insulin-like growth factor 
(IGF-1) and its receptor IGF-1R alterations have been implicated in cases of hyperglyce-
mia with resultant diabetic keratopathy. This disease is associated with superficial punctate 
keratitis, recurrent corneal erosions, and persistent epithelial defects in addition to severe 
neuroepithelial dysfunction. Moreover, the interaction of IGF-1R with its twin insulin recep-
tor (INSR) to form a hybrid receptor (the Hybrid-R) has been reported. The Hybrid-R was 
detected in the corneal epithelial cell nuclei where it interacts with DNA and is proposed to 
control gene expression important in maintaining ocular surface biology [4].
2.3.2. Bowman’s layer
Bowman’s layer lies directly underneath the basal lamina. As the name implies, this stratum 
is a layer and not a true membrane with the absence of staining by periodic acid-Schiff (PAS) 
stain. It is an acellular layer that cannot regenerate forming a scar after injury. It has a thick-
ness of 8–12 μm. Similar to the corneal stroma, it is composed of type I and type V collagen, 
but in contrast to the stroma, the ratio of type V to type I is higher. In addition, unlike the 
stroma, the collagen lamellae are smaller and more randomly arranged. The limbus starts at 
the peripheral termination of this layer [1].
Bowman’s layer is a key factor in maintaining the corneal biomechanical properties by its stiff 
and tough nature. Abnormalities of this layer can result in corneal ecstatic disorders such as 
keratoconus due to biomechanical failure [5].
2.3.3. Stroma
The corneal stroma occupies 90–95% of the thickness of the cornea. It is derived from the 
neural crest cells. In the center, it measures about 500 μm, while it becomes thicker toward 
the periphery. It is formed by proteoglycans (keratan sulfate and dermatan sulfate) covalently 
linked to a nucleus of a protein and a large number of collagen fibrils arranged parallel to the 
surface of the cornea. These corneal stromal collagen lamellae (200–250 lamellae) are com-
posed principally of type I and type V, with lesser amounts of types III and VI. The distance 
between these lamellae, occupied by proteoglycans, is constant. This property is very impor-
tant in maintaining the corneal transparency by eliminating any interference with light trans-
mission [1]. A relatively recently introduced layer, the pre-Descemet’s layer (Dua’s layer), is 
an acellular layer measuring approximately 10 μm and is found in the posterior stroma [6]. 
Among these collagen fibrils, we find the keratocytes, which are specialized fibroblasts that 
synthesize collagen and proteoglycans. There are about 2.4 million keratocytes spread within 
the stroma with higher density being anterior. They are extremely active cells evident by 
abundant mitochondria, rough endoplasmic reticulum, and Golgi apparatuses. They are flat 
and evenly distributed. Their plasma membranes are fenestrated. Gap junctions are the con-
duits through which communication occurs. The cell density decreases with age at a slower 
rate than the corneal endothelium [1].
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The posterior portion of the stroma is typically wetter than the anterior one. This occurs 
because of the wetting effect of the aqueous humor posteriorly and the drying effect of the 
atmosphere anteriorly. Corneal stromal edema, as seen in cases of endothelial failure, will 
result in enlarged spacing between the lamellae and subsequent visual compromise [1].
2.3.4. Descemet’s membrane
Descemet’s membrane corresponds to the basal lamina of the corneal endothelium. It is a true 
basement membrane that is PAS-positive. Its thickness is variable and linked to the age of the 
individual as it is continuously secreted by the endothelium. In neonates, it measures 2–4 μm 
thick and reaches up to 10–12 μm by adulthood [1]. It has two histologically distinct layers: 
the anterior banded layer produced in utero and the posterior non-banded layer produced 
throughout life. It is composed of type IV collagen, laminin, and fibronectin [1].
Descemet’s membrane is fundamental in providing support and adhesion to the endothelial 
cells. In addition, it is resistant to the phagocytic, toxic, and enzymatic insults. However, it is 
relatively weakly attached to the overlying stroma and, thus, can be surgically dissected as 
one piece [1].
2.3.5. Endothelium
The corneal endothelium is a monolayer located on the inner side of the cornea and is about 
4–6 μm thick. Similar to the stroma, the endothelium comes from neural crest cells. The cells 
cannot regenerate after birth. The endothelial cell density is about 3000 cells/mm2 with 500,000 
cells covering the posterior surface of the cornea. This number decreases slowly with age at 
a rate of 0.6% per year. The most common cell shape is hexagonal. Minimal variation in cell 
size (polymegathism) and cell shape (pleomorphism) can be seen in normal individuals. The 
endothelium has two principal functions aiming to maintain the corneal clarity: the barrier 
and the metabolic pump functions [1]. These cells are joined together by interdigitations that 
are only visible by an electron microscope. In addition, focal tight junctions can be seen in the 
apicolateral membranes. They communicate through gap junctions. The endothelial cell layer 
is relatively semipermeable to allow some nutrients to pass paracellularly to the remaining 
corneal layers [1].
The high metabolic demand of the endothelial cells is evident by the presence of numer-
ous mitochondria, the prominent smooth and rough endoplasmic reticulum, ribosomes, and 
Golgi apparatuses. Pinocytic vesicles can be seen in the cytoplasm pumping fluid from the 
stroma to the anterior chamber [1]. The endothelial pump requires the existence of bicarbon-
ate, the membrane bicarbonate transporters, Na-K ATPase, and carbonic anhydrase activity. 
Thus, corneas with low or relatively dysfunctional endothelial cells contraindicate the use of 
topical carbonic anhydrase inhibitors [4].
Peripheral corneal guttae (Hassall-Henle bodies) are minute excrescences that can be observed 
in the peripheral part of Descemet’s membrane. It is considered a natural aging process. They 
represent focal thickening of Descemet’s membrane. A histologically similar but pathologi-
cal in nature is the appearance of central cornea guttae. They are associated with progressive 
corneal stromal and epithelial edema representing Fuch’s endothelial dystrophy [1].
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3. Histopathology of ocular surface
Tumors of the ocular surface are the most frequent of the eye and appendages along with 
those of the eyelids. They cover a wide spectrum from benign lesions such as papilloma to 
others that may endanger the visual function and the life of the patient, such as squamous 
cell carcinoma and melanoma [6, 7]. They can arise from any of the cells that make up the 
conjunctiva although the most frequent are those of epithelial and melanocytic origins. The 
tumors of the conjunctiva can be epithelial (non-melanocytic and melanocytic) and stromal 
(lymphoproliferative, vascular, neural, lipomatous, histiocytic, myogenic, fibrous, and chori-
stomatous). In addition, tumors of the ocular surface encompass caruncular and metastatic 
tumors. This chapter will focus on the epithelial tumors.
3.1. Non-melanocytic epithelial tumors
3.1.1. Squamous papilloma
Squamous papilloma appears at any age with variable presentation [8]. Human papilloma viruses 
(HPV) 6, 11, or 16 result in the development of squamous papillomas in children [9]. Patients 
can present with pink, single or multiple, sessile, or pedunculated lesion in the inferior fornix 
and less commonly the bulbar conjunctiva. In older patients, papilloma can result in relation to 
HPV infection or in patients with compromised immunity [10]. Clinically, it usually presents 
as unilateral light pink mass at the limbus or the caruncle. It may have the appearance of squa-
mous cell carcinoma (SCC). In addition, squamous papilloma is a premalignant lesion and has 
been reported to transform to SCC, transitional cell carcinoma, or mucoepidermoid carcinoma 
particularly in the inverted growth pattern [11–13]. The lesion classically demonstrates many 
vascularized papillary fronds lined by the acanthotic epithelium with no evidence of pleomor-
phism or dysplasia (Figure 1).
3.1.2. Conjunctival pseudoepitheliomatous hyperplasia
This lesion is a benign inflammatory lesion manifested by a reactive proliferation of the con-
junctival epithelium. It is also called pseudocarcinomatous hyperplasia as it resembles malig-
nant lesions in clinical and histopathological examinations [7]. It is caused by irritation of the 
conjunctiva by a coexisting or previously existing stromal inflammation, foreign body, vernal 
keratoconjunctivitis, pterygium, and pinguecula. Clinically, a rapidly progressing elevated 
pink limbal lesion with leukoplakia and hyperkeratosis is seen. The histopathology shows 
an extensive acanthosis and hyperkeratosis in addition to parakeratosis of the conjunctival 
epithelium. There is no cytological atypia.
3.1.3. Keratoacanthoma
It is a rare variant of conjunctival pseudoepitheliomatous hyperplasia. A rapidly progressing 
hyperkeratotic lesion is seen [8, 14–16]. The documented cases have occurred on the bulbar 
conjunctiva, within the palpebral aperture, and adjacent to the limbus.
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3.1.4. Dacryoadenoma
Dacryoadenoma is an exceedingly rare condition occurring in children and adolescents. It is 
a benign tumor originating from the conjunctival epithelium and grows into the stroma form-
ing glandular lobules analogous to the lacrimal gland with goblet cells. Clinically, it appears 
as a translucent fleshy lesion anywhere in the conjunctiva [8, 12, 17].
3.1.5. Conjunctival keratotic plaque and actinic keratosis
These leukoplakic conjunctival lesions cannot be differentiated clinically. They usually arise 
in the interpalpebral region. Histologically, a conjunctival keratotic plaque is characterized by 
acanthosis, hyperkeratosis, and parakeratosis. There is no dyskeratosis. Typically, it has no 
malignant potential.
In actinic keratosis, a gradually progressing flat leukoplakic lesion that may frequently be 
indistinguishable from conjunctival intra-epithelial neoplasia (CIN) is observed [8, 12, 18]. 
Positive rose bengal staining of the lesion surface is seen in cases of CIN. Epithelial hyperpla-
sia acanthosis, keratosis, or parakeratosis are found in addition to some atypia. The basement 
membrane is intact.
3.1.6. Ocular surface squamous neoplasia (OSSN)
Ocular surface squamous neoplasia (OSSN) is a common term that describes a spectrum of 
benign, premalignant, and malignant epithelial lesions of the conjunctiva and cornea. Thus, 
OSSN encompasses conjunctival or corneal intraepithelial dysplasia, carcinoma in situ, and inva-
sive squamous cell carcinoma (SCC) [19]. Previously, the terms used to describe the spectrum of 
OSSN were Bowen’s disease, Bowenoid epithelioma, and intraepithelial epithelioma [20].
CIN approximately accounts for 4% of all conjunctival lesions and 39% of premalignant and 
malignant lesions of the ocular surface [21]. The incidence of invasive SCC is ranging from 
Figure 1. Histopathological image of a conjunctival squamous papilloma (original magnification ×50 hematoxylin and eosin).
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0.02 to 3.5/100,000 population [22]. Three quarters of cases occur in men and older patients 
and at the limbus, although any part of the conjunctiva or cornea may be affected mostly 
within the interpalpebral fissure [12, 21].
Risk factors associated with the development of OSSN are exposure to sunlight, HPV type 
16 infections, and immunodeficiency [12, 23]. In addition, xeroderma pigmentosum and 
Papillon-Lefevre syndrome are associated with recurrent OSSN, occurring in younger indi-
viduals [24]. Rarely, OSSN can be bilateral in immunosuppressed patients. Regional lymph 
node involvement and infrequently distant metastasis may occur.
Clinically, the lesion may appear fleshy, gelatinous, leukoplakic, or papillomatous. Leukoplakia 
is most likely due to hyperkeratosis or surface keratinization. Feeder vessels may be prominent, 
or the lesion may be avascular. As mentioned earlier, rose bengal staining can support the diag-
nosis and help in the demarcation of the tumor extent. It is essential to examine the tarsal con-
junctiva with upper eyelid eversion to look for extension or multifocal involvement. Clinical 
correlation with histological severity is unpredictable. Intraocular extension occurs in 2–15% 
of SCC patients for which enucleation and sometimes exenteration, if the orbit is invaded by 
the malignant process resulting in proptosis, are often needed [22, 25]. The limbal lesion may 
invade the adjacent corneal epithelium and appear as advancing superficial faint opacity that 
may be associated with subtle vascularization. Rarely, primary SCC of the cornea can occur. 
Additionally, there are no reliable clinical measures for characterizing the differences between 
CIN and invasive SCC. However, leukoplakia raises the suspicion of malignancy and is generally 
absent or insignificant in CIN. Extensive vascularity and nodularity of the lesion are in favor of 
SCC. Tumor thickness is not a reliable sign of malignant potential, as there are thick tumors that 
remain confined within the epithelium. Diffuse conjunctival involvement can masquerade as 
conjunctivitis-type symptoms and signs [26].
The typical cytological features that are seen in OSSN on impression cytology include pleo-
morphic cells with hyperchromatic nuclei having an irregular outline and prominent nucleoli. 
However, the diagnosis of OSSN using this tool is controversial as the previously mentioned 
features might not be seen in the superficial layers overlying the tumor [27]. Thus, it is less 
sensitive in regard to the diagnosis of SCC. In addition, it cannot differentiate between CIN 
and invasive SCC. Hence, biopsy in suspected cases is advisable [28].
The histopathological examination of an incisional or excisional biopsy is of central role in 
OSSN diagnosis and treatment plan. The submitted conjunctival tissue is flattened with the 
mucosal surface directed upward using a filter paper with special attention to the proper 
orientation of the specimen. After being left to dry, it is placed in 10% buffered formalin 
[19]. Histopathologically, the lesion can show any of the following spectra: conjunctival epi-
thelial dysplasia in which dysplastic cells are confined to the basal epithelial layer and/or 
carcinoma in situ where the full thickness of the epithelium is occupied by dysplastic cells 
with characteristic abrupt demarcation between the dysplastic epithelium and the normal 
epithelium (Figures 2 and 3). Invasive squamous cell carcinoma occurs when the underlying 
basement membrane is violated (Figure 4). The first two are sometimes termed conjunctival/
corneal intraepithelial neoplasia (CCIN). The dysplasia is further classified into mild, moder-
ate, and severe grades based on the level of epithelial thickness involvement. Mild dysplasia 
shows dysplastic cells in the lower one-third of the epithelium, while moderate dysplasia is 
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involving the lower two-thirds. The histological characteristics of epithelial dysplasia include 
loss of polarity, increased nuclear-cytoplasmic ratio, increased number of mitotic figures, 
cellular polymorphism, nuclear hyperchromatism, and enlarged nucleoli. Conjunctival SCC 
that closely resembles the structure of the normal epithelium with keratinization is described 
as being well-differentiated. A tumor that resembles the original tissue to a lesser extent is 
termed poorly differentiated.
Increasing age, large size tumors, involvement of the surgical margins, and high Ki-67 pro-
liferation index are risk factors for recurrence of OSSN [25]. Fortunately, with the invention 
of new treatment modalities, the prognosis has improved with an overall recurrence rate of 
approximately 5% and regional lymph node metastasis of less than 2% [19].
SCC is classified depending on the size, tumor location, and the extent of involvement as per 
the American Joint Committee on Cancer (AJCC) with consideration to the primary tumor 
Figure 2. A case of conjunctival squamous cell carcinoma in situ with a transition from normal conjunctival epithelium 
to the dysplastic epithelium (original magnification ×200 hematoxylin and eosin).
Figure 3. Another case of conjunctival squamous cell carcinoma in situ with intact basement membrane and adjacent 
area of normal conjunctival epithelium (original magnification ×200 hematoxylin and eosin).
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features, lymph node involvement, and metastasis represented using (TNM) classification. 
Highly malignant variants include spindle cell squamous carcinoma (Figure 5), mucoepider-
moid carcinoma, and adenoid SCC [8, 12, 23, 29, 30, 31].
The concept of molecular genetics in cases of OSSN and ocular oncology has expanded in the 
recent years. It studies the interaction between genes and protein with attention to the activity 
patterns in different neoplastic cells. Alterations on chromosome 8 with 8p11.22 amplifica-
tions have been described in 75% of the tumors. This region encompasses a group of genes 
that code for ADAM proteins. One of the genes in this group is involved in oral SCC. In addi-
tion, Collagen type I alpha1 (COL1A1) is also found in ocular cases and was identified to be 
upregulated in oral squamous cell carcinoma [32, 33].
Figure 5. A case of conjunctival spindle cell carcinoma with wavy pattern of spindle cells and high degree of pleomor-
phism (original magnification ×100 Periodic acid-Schiff).
Figure 4. A case of conjunctival invasive squamous cell carcinoma with superficial keratinization (original magnification 
×200 hematoxylin and eosin).
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3.2. Melanocytic epithelial tumors
Melanocytic conjunctival lesions have a wide spectrum of disorders. They range from benign 
to highly malignant fatal tumors. In the following subsections, the most common differential 
diagnoses of melanocytic conjunctival lesions will be discussed.
3.2.1. Conjunctival nevus
Conjunctival nevi are the most common melanocytic conjunctival tumors. Conjunctival nevi 
usually start to appear in children or adolescents as a group of pigmented cells in the basal 
layer of the conjunctival epithelium. Conjunctival nevi are more prevalent in Caucasians (89%) 
with Africans (6%) and Asians (5%) being less commonly affected [33]. Conjunctival nevi are 
typically pigmented, but approximately 16% can be amelanotic or partially pigmented [12, 34]. 
Juxta-limbal location is the most common location occurring in more than two-thirds of patients. 
Other locations include the caruncle, plica semilunaris, fornix, tarsus, and cornea [34, 35].
There are three types of conjunctival nevi based on their histological location: compound, 
subepithelial, and junctional nevi being the least common. Compound nevi are characterized 
by the presence of melanocytic cells at the epithelial-subepithelial junction and within the 
stroma (Figure 6). Subepithelial lesions are located solely in the subepithelial area. They are 
often associated with epithelial inclusions cysts and goblet cells (Figure 7). Junctional nevi 
consist of nests of nevus cells at the epithelial-subepithelial junction. They are rare except in 
children. These types are considered more of phases of migration of the nevus cells from the 
basal epithelium to the conjunctival stroma.
Malignant transformation was estimated to be <1% [21, 35]. However, new onset in middle 
age or later in life, unusual location (i.e., fornix, tarsus, caruncle, plica), large lesions more than 
10 mm in diameter, prominent feeder vessel or intrinsic vascularity with hemorrhage, non-
cystic lesions, and non-mobile lesions (i.e., fixed to the underlying episclera) are clinical indica-
tions to excise the lesion [36].
3.2.2. Complexion-associated melanosis (CAM)
CAM, also known as racial melanosis, is a benign bilateral conjunctival lesion found among 
darkly pigmented individuals [8, 12]. It is typically observed in the peri-limbal area and 
uncommonly in the fornix or palpebral conjunctiva. On examination, variably pigmented non-
cystic flat lesions are observed.
3.2.3. Primary acquired melanosis (PAM)
PAM is defined as melanocytic proliferation in the conjunctival epithelium. It is more fre-
quent in light-skinned individuals and is usually unilateral. It typically begins insidiously in 
the middle age. Sunlight exposure may be a risk factor in the development of PAM. It may 
originate from an abnormality in neural crest as it has also been seen in patients with neuro-
fibromatosis [37].
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It presents as a flat brown, superficial, non-cystic, solitary, patchy, diffuse, or multifocal pigmen-
tation involving bulbar, forniceal, and palpebral conjunctiva or cornea. Amelanotic PAM can 
be occasionally seen [8, 21, 38]. Cellular atypia, determined by biopsy and careful histopatho-
logical examination, aided by immunohistochemical staining (using Melan-A stain to highlight 
the melanocytes), is the principal risk factor for progression to melanoma (Figures 8 and 9). In 
one study of 311 eyes with PAM, lesions without atypia or with mild atypia demonstrated 0% 
progression into melanoma. On the other hand, 13% of patients having PAM with severe atypia 
progressed into melanoma [21].
Clinical indications to perform a biopsy include ≥5 mm lesion diameter, progression, thick-
ening, the appearance of a nodule, vascularity, involvement of the palpebral conjunctiva or 
cornea, patients with personal or family history of dysplastic nevus syndrome, and history of 
ocular or extraocular melanoma [12].
Figure 6. Histopathological appearance of a compound conjunctival nevus with nests of nevus cells at the base of the 
conjunctival epithelium and within the substantia propria (original magnification ×50 hematoxylin and eosin).
Figure 7. Histopathological appearance of a subepithelial conjunctival nevus with cystic areas lined by the conjunctival 
epithelium and goblet cells within the substantia propria (original magnification ×100 periodic acid-Schiff).
Histopathology - An Update78
3.2.4. Conjunctival melanoma
Conjunctival melanoma, although rare, represents the second most frequent malignant con-
junctival lesion after squamous cell carcinoma [39]. In the past, its evolution almost invariably 
resulted in an unfavorable prognosis, resulting in orbital exenteration in an attempt to eradi-
cate the highly invasive disease. It represents a challenge for the clinician and pathologist 
because it can present in several pictures and originates from apparently benign lesions such 
as conjunctival nevi [40]. Conjunctival melanoma most frequently affects white individuals 
with an incidence varying from 0.24 to 0.80/1,000,000 population [41, 42]. It is more frequent 
in elderly individuals with a mean age ranging from 55 to 70 years [41–47]. Although rare in 
Figure 8. Histopathological appearance of conjunctival primary acquired melanosis (PAM) with melanocytic proliferation 
at the base of the conjunctival epithelium without evidence of atypia (original magnification ×200 hematoxylin and eosin).
Figure 9. Immunohistochemical staining of another case of conjunctival primary acquired melanosis (PAM) showing 
clearly the melanocytic proliferation at the base of the conjunctival epithelium without evidence of atypia (original 
magnification ×200 Melan-A).
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young people, there are reports of conjunctival melanoma cases in patients less than 20 years 
of age [48, 49]. There is no significant difference between men and women [41–47].
Conjunctival melanoma arises from PAM in 75% of cases, preexisting nevus in 20%, and de 
novo in 5% [8, 12]. Systemic risk factors include dysplastic nevus syndrome, neurofibromatosis, 
and xeroderma pigmentosum [38]. Sunlight exposure is also suggested as a cause in the devel-
opment of bulbar conjunctival melanoma. The most frequent location of conjunctival mela-
noma is the bulbar conjunctiva in the peri-limbal area, but it can occur in any location, such 
as the palpebral or forniceal conjunctiva, the plica, or the region of the caruncle [45, 47, 50, 51].
Clinically, conjunctival melanomas may have variable presentations. Classically, it presents 
as a mass or an elevated pigmented conjunctival lesion. In some cases, it may appear more 
diffuse or multiple, with poorly defined borders, particularly when associated with PAM [22]. 
Less commonly, conjunctival melanomas can present as a pink or reddish pigmented lesion or 
can be even amelanotic, making it difficult to recognize and, thus, delaying its diagnosis and 
treatment [47]. Moreover, the recurrence of conjunctival melanoma after excision is typically 
amelanotic [12]. Repeated and continuous contact of the conjunctiva from an adjacent eyelid 
margin melanoma may cause a secondary conjunctival melanoma (implantation melanoma) 
[52]. Like SCC, conjunctival melanoma is classified according to the AJCC-TNM classifica-
tion. Conjunctival melanomas can metastasize regionally to pre-auricular and submandibular 
lymph nodes. Distant metastasis involves the brain, liver, skin, and bone [53].
Conjunctival melanocytic intra-epithelial neoplasia (C-MIN) is a term used to describe lesions 
exhibiting proliferation of melanocytes. Scoring of C-MIN is based on several factors includ-
ing the pattern of horizontal and vertical epithelial involvement, the degree of cellular atypia, 
nuclear and cellular diameter, and the presence of nucleoli and mitotic figures. Then, C-MIN 
is graded from 0 to 10 with 0 corresponding to an absence of any melanocytic proliferation or 
atypia (i.e., melanosis only), 1–4 corresponding to the severity of PAM (i.e., mild, moderate, 
and severe atypia), and 5–10 corresponding to conjunctival melanoma in situ (Figure 10) [54].
Figure 10. Histopathological appearance of conjunctival melanoma in situ with atypical melanocytic proliferation 
involving the full thickness of the conjunctival epithelium (original magnification ×200 periodic acid-Schiff).
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The lesions usually demonstrate atypical melanocytic proliferation characterized by abundant 
cytoplasm, prominent nucleoli, and atypical mitotic figures with invasion of the underlying 
conjunctival stroma as well as the adjacent epithelium. Atypical melanocytic proliferation can 
be limited to the epithelium in the early stages in cases arising from PAM (melanoma in situ) 
with radial spread in a similar way to cutaneous melanomas. The entire lesion should be 
removed in one piece without touching it by excising it along the limbus to prevent seeding 
of the tumor cells in the surgical area.
Pathological examination of the excised lesion should include observation of important fea-
tures such as ulceration, thickness of the tumor and its predominant histologic cell type (i.e., 
epithelioid or spindle), and the vertical growth phase. Other important characteristics include 
lymphocytic infiltration, vascular or perineural invasion, and the mitotic activity detected 
using Ki-67 index. In addition, microscopic satellitosis—defined as separate nests of tumor 
disconnected from the main malignant mass—should be also observed [55].
Evident histopathological features that are associated with worse survival include tumor 
thickness more than 2 mm, the presence of ulceration, epithelioid morphology, higher count 
of mitotic figures (>1/mm2), lymphovascular invasion, and microsatellitosis [55, 56]. Extra-
bulbar conjunctival melanoma is found in a multivariate analysis study to be associated with 
poor outcome [57].
Immunohistochemical (IHC) stains for melanocytes such as Melan-A red, MART-1, S-100 pro-
tein, HMB-45, and the cell proliferative marker Ki-67 may help to identify melanocytic prob-
lematic cases. In conjunctival melanomas, the immunohistochemical expression of HMB-45 
and Ki-67 is higher than what is observed in PAM or conjunctival nevi [58]. Beta-catenin is an 
IHC marker that was more strongly expressed in conjunctival melanomas compared to nevi 
and PAM. Thus, its role in conjunctival melanomas is different than cutaneous melanoma, 
in which loss of beta-catenin expression has been associated with a more aggressive course 
[58]. Programmed cell death protein 1 (PD-1) and its interaction with its ligand PD-L1 studied 
in patients with conjunctival melanoma has shown increased risk of distant metastases and 
worse survival when expressed by the tumor [59].
BRAF is a human gene that encodes a protein called B-Raf, a proto-oncogene. Conjunctival 
melanoma is one of the BRAF mutation-associated malignancies. A higher chance of distant 
metastasis might be seen in conjunctival melanomas expressing BRAF mutations. Conjunctival 
melanoma and cutaneous melanoma show resemblance in the significance of this type of 
mutation and its relevance to the clinical presentation [57, 60].
Advanced therapy of conjunctival melanomas using cryotherapy, radiotherapy, and che-
motherapy has lowered the frequency of surgical exenteration. It is essential to perform 
periodic systemic screening in high-risk patients [54]. Local recurrence after therapy 
ranges from 50 to 70% at 10 years with an overall mortality rate of 25% at 10 years and 
more than 30% at 15 years [21]. Multifocal melanomas, extra-limbal location, incomplete 
surgical excision, and the lack of additional treatment are considered to be risk factors for 
recurrence [54, 57].
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